Publication | Closed Access

Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China

VaccinationHemodialysisHemodialysis PatientsViral HepatitisLong-term Persistent ImmunogenicityImmunologyHepatitis BHepatitisDialysis TherapySuccessful StandardVaccine EfficacyMedicineVaccine Research